Daniel Kim is a seasoned financial executive with extensive experience in business management and relationship development in the finance sector. They served as Director at Fitch Ratings from 2016 to 2020, leading issuer coverage and investor development. Previously, they have held key roles at companies such as Bloomberg LP, GE Capital, and Deutsche Bank, where they managed various financial services. Currently, they are the CFO at Cerecin Inc., an innovative biotech company, and have also been the CFO of ONCOCROSS Co., Ltd., which is set to IPO in December 2024. Daniel holds a Master’s Degree in International Relations from Yonsei University and has further specialized in Artificial Intelligence in Healthcare through MIT Sloan Executive Education.
This person is not in the org chart
This person is not in any teams
This person is not in any offices